COVID-19 is associated with the risk of cardiovascular disease death: A two-sample Mendelian randomization study

Jia-Peng Miao1, Xiao-Yu Gu2, Rui-Zheng Shi1

  • 1Department of Cardiovascular Medicine, Xiangya Hospital, Central South University, Changsha, China.

Insights

Infections from Coronavirus disease 2019 (COVID-19) increase the risk of death from cardiovascular disease. This study found that both COVID-19 susceptibility and hospitalization causally link to cardiovascular disease mortality.

Area of Science:

  • Cardiovascular Epidemiology
  • Infectious Disease Epidemiology
  • Genetic Epidemiology

Background:

  • The long-term cardiovascular implications of Coronavirus disease 2019 (COVID-19) remain a significant public health concern.
  • Understanding the causal relationship between COVID-19 and cardiovascular disease (CVD) outcomes is crucial for risk stratification and prevention.

Purpose of the Study:

  • To investigate the potential causal effects of COVID-19 susceptibility and hospitalization on the risk of death from cardiovascular disease.
  • To employ robust genetic epidemiological methods to establish causality.

Main Methods:

  • Utilized two-sample Mendelian randomization (MR) analysis with summary statistics from large genome-wide association studies (GWAS).
  • Included data from over 2.5 million participants for COVID-19 susceptibility, hospitalization, and CVD death.
  • Performed sensitivity analyses including MR-Egger regression, heterogeneity tests, and Leave-one-out analyses to ensure result validity.

Main Results:

  • COVID-19 susceptibility was found to be a causal factor for cardiovascular disease death (β = 2.188 × 10⁻³, P = 0.002).
  • COVID-19 hospitalization also demonstrated a causal link to cardiovascular disease death (β = 8.626 × 10⁻⁴, P = 0.010).
  • Sensitivity and reverse MR analyses confirmed the absence of significant heterogeneity, horizontal pleiotropy, or reverse causality.

Conclusions:

  • Bidirectional MR analysis provides strong evidence for a causal relationship between COVID-19 (both susceptibility and hospitalization) and an increased risk of cardiovascular disease death.
  • These findings underscore the importance of managing cardiovascular risk in individuals affected by COVID-19.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
47
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
65
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
25
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
25
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
36